side effects of tirzepatide Common Demystified Tirzepatide Overview - Rebound Clinics

Ipamorelin: Fat Loss & Muscle Growth Ipamorelin is a selective growth hormone secretagogue (GHS), meaning it stimulates the release of growth hormone from the pituitary gland without affecting other hormones like cortisol or prolactin

1 Classification of glucagon-like peptide 1 (GLP-1) therapies in clinical use or in development

Previous studies of individuals affected by type 1 diabetes [37, 38] and AAb+ individuals [36] have revealed increased serum IGFBP1 levels

Obesity is characterized by impaired glucose uptake by the muscles and the liver

India Patent expires: March 2026 Adult population: 947 million Proportion of adults living with obesity a : 8% Proportion of adults living with diabetes b : 11% China Patent expires: March 2026 Adult population: 1.07 billion Proportion of adults living with obesity a : 9% Proportion of adults living with diabetes b : 12% Brazil Patent expires: March 2026 Adult population: 155 million Proportion of adults living with obesity a : 31% Proportion of adults living with diabetes b : 11% Trkiye Patent expires: 2026 Adult population: 59.0 million Proportion of adults living with obesity a : 36% Proportion of adults living with diabetes b : 16% Canada Patent expires: 2026 Adult population: 29.1 million Proportion of adults living with obesity a : 27% Proportion of adults living with diabetes b : 10% World Population: 8.23 billion More than 1 billion people in the world have a body mass index (BMI) 30 kg/m 2

Cardiovascular and Renal Benefits Figure 3